Literature DB >> 6177245

Application of fluorescein angiography in retinoblastoma.

Y Ohnishi, Y Yamana, M Minei, H Ibayashi.   

Abstract

Although a slight dilatation of the retinal capillaries is the only significant fluorescein angiographic finding in retinoblastoma when the tumor is less than 0.5 disk diameter in size, microaneurysms become distinct in the tumor after it attains a size of 1 disk diameter. As growth of the tumor progresses, blood vessels within the tumor become thicker and permeability increases; eventually neovascularization occurs. When the tumor exceeds 3 disk diameters in size, the feeder arteries and drainage veins become dilated and tortuous. With healing of the retinoblastoma, light fluorescent stains and thick vessels are no longer demonstrable and the dye is visible in the sclera during later periods. A recurrent tumor is visible as a white fluffy mass in which the fluorescent dye accumulates. Occasionally a thick vessel stemming from the scar can be detected in a recurrent tumor.

Entities:  

Mesh:

Year:  1982        PMID: 6177245     DOI: 10.1016/s0002-9394(14)77372-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Optical Coherence Tomography Angiography Microvascular Variations in Pre- and Posttreatment of Retinoblastoma Tumors.

Authors:  Juan P Fernandez; Asghar A Haider; Lejla Vajzovic; Arathi Ponugoti; Michael P Kelly; Miguel A Materin
Journal:  Ocul Oncol Pathol       Date:  2021-06-02

2.  [Retinoblastoma].

Authors:  N Bornfeld; D Lohmann; N E Bechrakis; E Biewald
Journal:  Ophthalmologe       Date:  2020-04       Impact factor: 1.059

3.  Microvascular Features of Treated Retinoblastoma Tumors in Children Assessed Using OCTA.

Authors:  Akshay S Thomas; S Tammy Hsu; Robert J House; Avni P Finn; Michael P Kelly; Cynthia A Toth; Miguel A Materin; Lejla Vajzovic
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-12-01       Impact factor: 1.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.